{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nerve+Palsy", "query": { "condition": "Nerve Palsy" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 166, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nerve+Palsy&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-08T15:12:08.457Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04014387", "title": "Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Progressive Supranuclear Palsy(PSP)", "Insomnia" ], "interventions": [ { "name": "Suvorexant", "type": "DRUG" }, { "name": "Zolpidem", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2019-06-02", "completion_date": "2025-06-30", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04014387" }, { "nct_id": "NCT01348061", "title": "Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alzheimer Disease", "Progressive Supranuclear Palsy" ], "interventions": [], "intervention_types": [], "sponsor": "KineMed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 16, "start_date": "2011-07", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2014-10-24", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 3, "location_summary": "Glendale, California • Eatontown, New Jersey • San Antonio, Texas", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Eatontown", "state": "New Jersey" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01348061" }, { "nct_id": "NCT03058965", "title": "Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alzheimer Disease", "Healthy Volunteers", "Progressive Supranuclear Palsy" ], "interventions": [ { "name": "[18F]MNI-958", "type": "DRUG" }, { "name": "[18F]Florbetapir", "type": "DRUG" }, { "name": "DaTscan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Molecular NeuroImaging", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "50 Years to 90 Years" }, "enrollment_count": 12, "start_date": "2016-11-29", "completion_date": "2018-05-11", "has_results": false, "last_update_posted_date": "2019-03-25", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03058965" }, { "nct_id": "NCT06288763", "title": "Nerve Transfer to Improve Function in High Level Tetraplegia", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Spinal Cord Injury", "Tetraplegia" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2024-02-05", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 9, "location_summary": "Stanford, California • Miami, Florida • Baltimore, Maryland + 6 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06288763" }, { "nct_id": "NCT00064571", "title": "Surgery for Vocal Cord Paralysis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Unilateral Vocal Cord Paralysis" ], "interventions": [ { "name": "vocal fold medialization", "type": "PROCEDURE" }, { "name": "vocal fold reinnervation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Institute on Deafness and Other Communication Disorders (NIDCD)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2002-10", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2006-04-24", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Irvine, California • Washington D.C., District of Columbia + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Irvine", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00064571" }, { "nct_id": "NCT05913687", "title": "Automated Imaging Differentiation of Parkinsonism", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Multiple System Atrophy, Parkinson Variant", "Progressive Supranuclear Palsy" ], "interventions": [ { "name": "AIDP", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 315, "start_date": "2021-07-22", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 19, "location_summary": "Birmingham, Alabama • La Jolla, California • San Francisco, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05913687" }, { "nct_id": "NCT06932809", "title": "Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Tauopathies" ], "interventions": [ { "name": "18F-JSS20-183A PET", "type": "DRUG" }, { "name": "Brain MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Amyloid PET", "type": "DIAGNOSTIC_TEST" }, { "name": "Neurological Assessments", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 90, "start_date": "2025-05-09", "completion_date": "2030-04", "has_results": false, "last_update_posted_date": "2025-12-23", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 2, "location_summary": "San Francisco, California • Philadelphia, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06932809" }, { "nct_id": "NCT01049399", "title": "Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Progressive Supranuclear Palsy" ], "interventions": [ { "name": "tideglusib", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Noscira SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 146, "start_date": "2009-12", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2012-01-05", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 6, "location_summary": "Fountain Valley, California • Los Angeles, California • Jacksonville, Florida + 3 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01049399" }, { "nct_id": "NCT06243718", "title": "Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diaphragmatic Paralysis", "Pain, Chest", "Breath Shortness" ], "interventions": [], "intervention_types": [], "sponsor": "Advanced Reconstructive Surgery Alliance", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 45, "start_date": "2023-10-10", "completion_date": "2026-10-10", "has_results": false, "last_update_posted_date": "2024-02-06", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 2, "location_summary": "Red Bank, New Jersey • Shrewsbury, New Jersey", "locations": [ { "city": "Red Bank", "state": "New Jersey" }, { "city": "Shrewsbury", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06243718" }, { "nct_id": "NCT04363684", "title": "ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Frontotemporal Lobar Degeneration (FTLD)", "Progressive Supranuclear Palsy (PSP)", "Corticobasal Degeneration (CBD)", "Behavioral Variant Frontotemporal Dementia (bvFTD)", "Semantic Variant Primary Progressive Aphasia (svPPA)", "Nonfluent Variant Primary Progressive Aphasia (nfvPPA)", "FTD With Amyotrophic Lateral Sclerosis (FTD/ALS)", "Amyotrophic Lateral Sclerosis", "Oligosymptomatic PSP (oPSP)", "C9orf72", "GRN Related Frontotemporal Dementia", "MAPT Gene Mutation", "TBK1 Gene Mutation", "Oligosymptomatic Progressive Supranuclear Palsy" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2100, "start_date": "2020-03-01", "completion_date": "2030-08-31", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-08T15:12:08.457Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04363684" } ] }